Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,832 | 11,244 | 37,142 | 70,628 | 78,900 |
| Marketable Securities | 29,671 | 43,073 | 26,582 | N/A | N/A |
| TOTAL | $50,075 | $57,917 | $67,290 | $74,790 | $80,980 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 698 | 365 | 1,361 | 1,380 | 546 |
| TOTAL | $698 | $365 | $1,361 | $1,380 | $546 |
| Total Assets | $50,773 | $58,282 | $68,651 | $76,170 | $81,526 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,224 | 1,964 | 2,917 | 2,456 | 2,519 |
| Accrued Expenses | 2,462 | 3,474 | 4,678 | 4,930 | 4,638 |
| TOTAL | $4,831 | $5,488 | $7,682 | $7,626 | $7,512 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 118 | 211 |
| Other Non-Current Liabilities | 221 | 0 | 0 | 0 | 13 |
| TOTAL | $758 | $306 | $N/A | $N/A | $13 |
| Total Liabilities | $5,589 | $5,794 | $7,682 | $7,626 | $7,525 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,948 | 2,936 | 2,936 | 2,817 | 2,661 |
| Common Shares | 59 | 59 | 3 | 56 | 52 |
| Retained earnings | -178,753 | -169,787 | -158,300 | -146,900 | -135,775 |
| Other shareholders' equity | -6 | 11 | 9 | 0 | 0 |
| TOTAL | $45,184 | $52,488 | $60,969 | $68,544 | $74,001 |
| Total Liabilities And Equity | $50,773 | $58,282 | $68,651 | $76,170 | $81,526 |